BioAlliance Pharma Release: Disclosure Of Total Number Of Voting Rights And Number Of Shares In The Capital At December 31, 2008

Paris, January 6th, 2009 – Pursuant to article L.233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority):